Cue Biopharma
29 hedge funds and large institutions have $25.9M invested in Cue Biopharma in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$7.03M | |
2 | +$6.35M | |
3 | +$5.55M | |
4 |
State Street
Boston,
Massachusetts
|
+$1.66M |
5 |
Northern Trust
Chicago,
Illinois
|
+$1.06M |
Top Sellers
No sellers this quarter